201 related articles for article (PubMed ID: 27427769)
1. A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme.
Bullard-Feibelman KM; Fuller BP; Geiss BJ
PLoS One; 2016; 11(7):e0158923. PubMed ID: 27427769
[TBL] [Abstract][Full Text] [Related]
2. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.
Feibelman KM; Fuller BP; Li L; LaBarbera DV; Geiss BJ
Antiviral Res; 2018 Jun; 154():124-131. PubMed ID: 29680670
[TBL] [Abstract][Full Text] [Related]
3. Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme.
Kaur R; Mudgal R; Narwal M; Tomar S
Virus Res; 2018 Sep; 256():209-218. PubMed ID: 29958924
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase.
Mudgal R; Mahajan S; Tomar S
FEBS Lett; 2020 Feb; 594(4):678-694. PubMed ID: 31623018
[TBL] [Abstract][Full Text] [Related]
5. Guanosine nucleotide analogs as inhibitors of alphavirus mRNA capping enzyme.
Lampio A; Ahola T; Darzynkiewicz E; Stepinski J; Jankowska-Anyszka M; Kääriäinen L
Antiviral Res; 1999 May; 42(1):35-46. PubMed ID: 10333141
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1.
Gigante A; Gómez-SanJuan A; Delang L; Li C; Bueno O; Gamo AM; Priego EM; Camarasa MJ; Jochmans D; Leyssen P; Decroly E; Coutard B; Querat G; Neyts J; Pérez-Pérez MJ
Antiviral Res; 2017 Aug; 144():216-222. PubMed ID: 28619679
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development.
Geiss BJ; Stahla-Beek HJ; Hannah AM; Gari HH; Henderson BR; Saeedi BJ; Keenan SM
J Biomol Screen; 2011 Sep; 16(8):852-61. PubMed ID: 21788392
[TBL] [Abstract][Full Text] [Related]
8. Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.
Abdelnabi R; Kovacikova K; Moesslacher J; Donckers K; Battisti V; Leyssen P; Langer T; Puerstinger G; Quérat G; Li C; Decroly E; Tas A; Marchand A; Chaltin P; Coutard B; van Hemert M; Neyts J; Delang L
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340991
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into viral RNA capping and plasma membrane targeting by Chikungunya virus nonstructural protein 1.
Zhang K; Law YS; Law MCY; Tan YB; Wirawan M; Luo D
Cell Host Microbe; 2021 May; 29(5):757-764.e3. PubMed ID: 33730549
[TBL] [Abstract][Full Text] [Related]
10. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
[TBL] [Abstract][Full Text] [Related]
11. Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores.
Jones R; Hons M; Rabah N; Zamarreño N; Arranz R; Reguera J
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2213934120. PubMed ID: 36913573
[TBL] [Abstract][Full Text] [Related]
12. Critical residues for GTP methylation and formation of the covalent m7GMP-enzyme intermediate in the capping enzyme domain of bamboo mosaic virus.
Huang YL; Han YT; Chang YT; Hsu YH; Meng M
J Virol; 2004 Feb; 78(3):1271-80. PubMed ID: 14722282
[TBL] [Abstract][Full Text] [Related]
13. Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP.
Ahola T; Kääriäinen L
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):507-11. PubMed ID: 7831320
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication.
Bakhache W; Neyret A; Bernard E; Merits A; Briant L
J Virol; 2020 May; 94(10):. PubMed ID: 32132240
[TBL] [Abstract][Full Text] [Related]
15. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay.
Ferreira-Ramos AS; Li C; Eydoux C; Contreras JM; Morice C; Quérat G; Gigante A; Pérez Pérez MJ; Jung ML; Canard B; Guillemot JC; Decroly E; Coutard B
Antiviral Res; 2019 Mar; 163():59-69. PubMed ID: 30639438
[TBL] [Abstract][Full Text] [Related]
16. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
[TBL] [Abstract][Full Text] [Related]
17. Critical residues of Semliki Forest virus RNA capping enzyme involved in methyltransferase and guanylyltransferase-like activities.
Ahola T; Laakkonen P; Vihinen H; Kääriäinen L
J Virol; 1997 Jan; 71(1):392-7. PubMed ID: 8985362
[TBL] [Abstract][Full Text] [Related]
18. 6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.
Kovacikova K; Morren BM; Tas A; Albulescu IC; van Rijswijk R; Jarhad DB; Shin YS; Jang MH; Kim G; Lee HW; Jeong LS; Snijder EJ; van Hemert MJ
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964798
[TBL] [Abstract][Full Text] [Related]
19. The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.
Delang L; Li C; Tas A; Quérat G; Albulescu IC; De Burghgraeve T; Guerrero NA; Gigante A; Piorkowski G; Decroly E; Jochmans D; Canard B; Snijder EJ; Pérez-Pérez MJ; van Hemert MJ; Coutard B; Leyssen P; Neyts J
Sci Rep; 2016 Aug; 6():31819. PubMed ID: 27545976
[TBL] [Abstract][Full Text] [Related]
20. Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses.
Ching KC; Kam YW; Merits A; Ng LF; Chai CL
J Med Chem; 2015 Dec; 58(23):9196-213. PubMed ID: 26540338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]